Serum amyloid A is a chemoattractant: induction of migration, adhesion, and tissue infiltration of monocytes and polymorphonuclear leukocytes
about
A seven-transmembrane, G protein-coupled receptor, FPRL1, mediates the chemotactic activity of serum amyloid A for human phagocytic cellsInflammatory effects of woodsmoke exposure among wildland firefighters working at prescribed burns at the Savannah River Site, SCAcute-phase, but not constitutive serum amyloid A (SAA) is chemotactic for cultured human aortic smooth muscle cellsThe acute phase protein Serum Amyloid A induces lipolysis and inflammation in human adipocytes through distinct pathwaysExtracellular matrix-anchored serum amyloid A preferentially induces mast cell adhesionAcute-phase serum amyloid A production by rheumatoid arthritis synovial tissueAn association between the acute phase response and patterns of antigen induced T cell proliferation in juvenile idiopathic arthritisTumour progression and metastasisNo evidence for a role of adipose tissue-derived serum amyloid a in the development of insulin resistance or obesity-related inflammation in hSAA1(+/-) transgenic miceNanomaterials vs Ambient Ultrafine Particles: an Opportunity to Exchange Toxicology KnowledgeSAA1 polymorphisms are associated with variation in antiangiogenic and tumor-suppressive activities in nasopharyngeal carcinomaBiological role of the N-formyl peptide receptorsA brief elevation of serum amyloid A is sufficient to increase atherosclerosisHepatic serum amyloid A1 aggravates T cell-mediated hepatitis by inducing chemokines via Toll-like receptor 2 in miceEx vivo and in vitro effect of serum amyloid a in the induction of macrophage M2 markers and efferocytosis of apoptotic neutrophilsSAA does not induce cytokine production in physiological conditionsRegulation of serum amyloid A protein expression during the acute-phase responseCutting edge: TLR2 is a functional receptor for acute-phase serum amyloid AHuman serum amyloid A has cytokine-like propertiesEndogenous Acute Phase Serum Amyloid A Lacks Pro-Inflammatory Activity, Contrasting the Two Recombinant Variants That Activate Human Neutrophils through Different ReceptorsSerum amyloid A: an acute-phase protein involved in tumour pathogenesisSerum amyloid A binding to CLA-1 (CD36 and LIMPII analogous-1) mediates serum amyloid A protein-induced activation of ERK1/2 and p38 mitogen-activated protein kinasesSerum amyloid A induces G-CSF expression and neutrophilia via Toll-like receptor 2Characterization of high affinity binding between laminin and the acute-phase protein, serum amyloid ADeficiency of endogenous acute phase serum amyloid A does not affect atherosclerotic lesions in apolipoprotein E-deficient miceParticle-induced pulmonary acute phase response may be the causal link between particle inhalation and cardiovascular diseaseParticle-induced pulmonary acute phase response correlates with neutrophil influx linking inhaled particles and cardiovascular riskCD36 is a novel serum amyloid A (SAA) receptor mediating SAA binding and SAA-induced signaling in human and rodent cellsCommensal microbiota stimulate systemic neutrophil migration through induction of serum amyloid A.Proteomic analysis of blood level of proteins before and after operation in patients with esophageal squamous cell carcinoma at high-incidence area in Henan Province.Serum amyloid A3 does not contribute to circulating SAA levelsPlasma biomarkers in a mouse model of preterm labor.SAA drives proinflammatory heterotypic macrophage differentiation in the lung via CSF-1R-dependent signaling.Human SR-BII mediates SAA uptake and contributes to SAA pro-inflammatory signaling in vitro and in vivoStructure and Expression of Different Serum Amyloid A (SAA) Variants and their Concentration-Dependent Functions During Host InsultsEpidermal growth factor receptor (EGFR) signaling is a key mediator of hormone-induced leukocyte infiltration in the pubertal female mammary glandSerum amyloid A induces NLRP-3-mediated IL-1β secretion in neutrophilsA pro-atherogenic HDL profile in coronary heart disease patients: an iTRAQ labelling-based proteomic approachComparative proteomic analysis of serum from patients with systemic sclerosis and sclerodermatous GVHD. Evidence of defective function of factor HTobacco smoke: a critical etiological factor for vascular impairment at the blood-brain barrier.
P2860
Q22008684-ABBD0DD8-11F1-40A7-8CF8-9D4D888CF01CQ23909994-EF621011-8592-4DC6-A244-B53E8C819FD8Q24293545-CA585AC7-08C1-4755-8773-F1A5EC6D5A84Q24317321-7072E157-9F20-4839-A3E3-50E605D8BF31Q24321924-871C3B98-01A0-4F96-9D5F-73FC27EBBDC3Q24792231-5CFB62A7-3062-4D9B-818B-DE82C18E4F0AQ24797623-DB7F1DDB-9114-47AE-9A69-7A34AF13C87DQ26766468-CEC3F0C5-7460-4DD8-9021-EF27C7086A99Q27309035-F1E3174C-CA2B-4268-B038-89EFB1BA8B04Q28073054-B86F77EA-845C-4733-9FAA-469B28A52FA1Q28235586-21495C04-98B9-42ED-8649-A917135C489CQ28239162-244C8FFC-8E8A-4BAA-A76B-7B78F9F1884CQ28252254-E42B745C-A616-4A48-94DD-9B54B57574BAQ28260051-2132C7F5-95AE-42E6-9FD7-41406CDCBA7EQ28260398-A4E236E9-F342-452D-A5B4-9C94152846F5Q28279562-F800769F-C9A1-4524-A390-122A3750854CQ28281545-4ED04D43-80BF-459F-B7CB-46A704C717C1Q28284501-493EA95D-865A-45BE-A8F3-245261CE5E24Q28286764-779FC8CD-DD28-492E-8703-AE48CCA8A61EQ28289800-BB0A941E-8872-43CF-8E7C-40140714ACDAQ28291806-2210C061-F73A-4A27-B910-BD1DF8652AB5Q28296257-3C34DD38-6EBD-4B3C-83F7-1271210803CDQ28298733-0F707E22-DA03-4C03-8EA1-36C46BF8CE1FQ28301233-EE4D558D-A17D-4DD7-B043-DBCAEF010E16Q28302517-D0EC5AB1-1496-49D6-B059-C353C5DE3534Q28385471-1CA1953F-AD2E-498F-A54E-3DAC677E9194Q28386194-9BDBA910-B3A9-4C70-89E2-E14249E23F1AQ28580132-48DEBFF3-B75D-4742-86EB-84429D3A0A34Q30629184-1D6BBAC7-5E99-4A14-8722-310703EF2A69Q33207901-A4D484F1-C116-44B1-A36B-3DBF48E49F3BQ33418206-B0127E49-D592-47C6-A15F-AC96FC66BFA7Q33418258-2718C421-4740-4CB8-AE28-3EAC850AE16BQ33576194-82783044-8247-4883-B7A2-A0133A636464Q33579601-EFFB020A-4B13-4695-A01D-F31CC5EDB4DAQ33604867-56B71CE2-855E-4D19-B4BC-391071857FEEQ33610623-337514FE-173C-40EA-B935-8BC827FC4D81Q33638132-08F9D0C0-F922-4A5A-98A4-8396765BA9DCQ33655192-EA89BC85-E915-4E8F-AB28-0243A8B55BACQ33668640-59A4B8A1-29E7-422C-B6A6-D758A7775B02Q33699683-E1D55F50-C527-459E-B49D-176E1C531CD8
P2860
Serum amyloid A is a chemoattractant: induction of migration, adhesion, and tissue infiltration of monocytes and polymorphonuclear leukocytes
description
1994 nî lūn-bûn
@nan
1994 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Serum amyloid A is a chemoattr ...... d polymorphonuclear leukocytes
@ast
Serum amyloid A is a chemoattr ...... d polymorphonuclear leukocytes
@en
Serum amyloid A is a chemoattr ...... d polymorphonuclear leukocytes
@en-gb
Serum amyloid A is a chemoattr ...... d polymorphonuclear leukocytes
@nl
type
label
Serum amyloid A is a chemoattr ...... d polymorphonuclear leukocytes
@ast
Serum amyloid A is a chemoattr ...... d polymorphonuclear leukocytes
@en
Serum amyloid A is a chemoattr ...... d polymorphonuclear leukocytes
@en-gb
Serum amyloid A is a chemoattr ...... d polymorphonuclear leukocytes
@nl
prefLabel
Serum amyloid A is a chemoattr ...... d polymorphonuclear leukocytes
@ast
Serum amyloid A is a chemoattr ...... d polymorphonuclear leukocytes
@en
Serum amyloid A is a chemoattr ...... d polymorphonuclear leukocytes
@en-gb
Serum amyloid A is a chemoattr ...... d polymorphonuclear leukocytes
@nl
P2093
P2860
P3181
P356
P1476
Serum amyloid A is a chemoattr ...... d polymorphonuclear leukocytes
@en
P2093
D F Michiel
D J Kelvin
J J Oppenheim
L L Bausserman
W J Murphy
P2860
P3181
P356
10.1084/JEM.180.1.203
P407
P577
1994-07-01T00:00:00Z